Furthermore, lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice had elevated expression of genes encoding components of the Srebf2 pathway, and their expression was suppressed when β-catenin/Tcf inhibitors were used. This evidence concerns the gene LCK and lymphoma.